Evaluation of the EBMT risk score and of a modified EBMT risk score adapted to paediatric patients in paediatric allogeneic transplantation

Type d'étude:

Numéro de l'étude:

Type de traitement à base de cellules souches:

Allogeneic

Maladies:

Titre court:

Objectif principal:

To assess EBMT risk score in paediatric allogeneic transplantation. To test a modified EBMT risk score with age classes adapted to paediatrics.

Principaux critères d'inclusion:

all patients
-Aged <18 Yrs at HSCT
-Allogeneic HSCT in an EBMT registered center for an acquired haematological disease
-Date of transplant between 01.01.2000 and 31.12.2012

Pays:

Investigateur principal:

Fanette Bernard

Coordinateur EBMT de l'étude:

Arnaud Dalissier